8.10 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
8.43
↗ 0.33 (4.12%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
8.43
↗ 0.33 (4.12%)
Market: CLOSED
Open?$8.16
High?$8.34
Low?$7.78
Prev. Close?$8.10
Volume?60.8K
Avg. Volume?47.0K
VWAP?$8.02
Rel. Volume?1.29x
Bid / Ask
Bid?$6.82 × 100
Ask?$9.85 × 100
Spread?$3.03
Midpoint?$8.34
Valuation & Ratios
Market Cap?77.6M
Shares Out?9.6M
Float?6.6M
Float %?72.7%
P/E Ratio?13.63
P/B Ratio?1.76
EPS?$0.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.56Strong
Quick Ratio?2.56Strong
Cash Ratio?2.37Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?13.6CHEAP▾
P/B?1.76CHEAP▾
P/S?98.41HIGH▾
P/FCF?89.8PRICEY▾
EV/EBITDA?-0.4CHEAP▾
EV/Sales?40.41HIGH▾
Returns & Efficiency
ROE?12.9%STRONG▾
ROA?4.1%FAIR▾
Cash Flow & Enterprise
FCF?$865.0K
Enterprise Value?$31.9M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
77.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626